JABRX
Price
$48.85
Change
+$0.15 (+0.31%)
Updated
Jul 17 closing price
Net Assets
27.03B
RLBCX
Price
$36.65
Change
+$0.09 (+0.25%)
Updated
Jul 17 closing price
Net Assets
251.77B
Interact to see
Advertisement

JABRX vs RLBCX

Header iconJABRX vs RLBCX Comparison
Open Charts JABRX vs RLBCXBanner chart's image
Janus Henderson Balanced S
Price$48.85
Change+$0.15 (+0.31%)
VolumeN/A
Net Assets27.03B
American Funds American Balanced R3
Price$36.65
Change+$0.09 (+0.25%)
VolumeN/A
Net Assets251.77B
JABRX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JABRX vs. RLBCX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABRX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. JABRX (27B). RLBCX pays higher dividends than JABRX: RLBCX (1.57) vs JABRX (1.47). JABRX was incepted earlier than RLBCX: JABRX (16 years) vs RLBCX (23 years). JABRX (1.07) is less costly to investors than RLBCX (0.89). JABRX is a more actively managed with annual turnover of: 76.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JABRX: RLBCX (250) vs JABRX (2500). RLBCX annual gain was more profitable for investors over the last year : 6.69 vs. JABRX (5.97). JABRX (38.46) and RLBCX (37.12) have equivalent 5 years return.
JABRXRLBCXJABRX / RLBCX
Total Expense Ratio1.070.89120%
Annual Report Gross Expense Ratio1.070.89120%
Fund Existence16 years23 years-
Gain YTD7.6877.94697%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets27B252B11%
Annual Yield % from dividends1.471.5794%
Returns for 1 year5.976.6989%
Returns for 3 years34.1534.9498%
Returns for 5 years38.4637.12104%
Returns for 10 years79.3859.39134%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WINT1.050.15
+16.67%
Windtree Therapeutics Inc.
LOOP1.310.08
+6.50%
Loop Industries
STLD131.153.68
+2.89%
Steel Dynamics
TSHA2.590.05
+1.97%
Taysha Gene Therapies
ADNT22.05-0.33
-1.47%
Adient plc